Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
Code | CSB-MP723346MO |
Abbreviation | Recombinant Mouse Mertk protein, partial (Active) |
MSDS | |
Size | $148 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
This Mouse Mertk recombinant protein was produced in Mammalian cell, where the gene sequence encoding Mouse Mertk (19-497aa) was expressed with the C-terminal 10xHis tag. The purity of this Mertk protein was greater than 95% by SDS-PAGE. The activity has been validated.
The mouse Mertk gene encodes a single-pass transmembrane protein with a relative molecular mass of about 110 KDa containing 994 amino acids. Mertk is a member of the receptor tyrosine kinase family, which is expressed in many tissues of the human body and participates in various physiological functions. Mertk is an important target in tumor therapy. Mertk reduces the phosphorylation levels of MAPK/ERK and PI3K/Akt, down-regulates the expression of BcH-2 protein, increases the cleavage of apoptosis-related protein caspase-3, and promotes cell apoptosis. The results of Twokoski et al. showed that Mertk could regulate the proliferation of melanoma cells by reducing the activation of Akt pathway and attenuating the activation of downstream signaling mammalian target of rapamycin and ribosomal protein S6 kinase, but had no significant effect on the activation of ERK pathway, suggesting that the effect of Mertk on melanoma proliferation is an Akt-dependent manner. Studies have shown that Mertk inhibitors can reduce glioblastoma cell adhesion, transform the cytoskeleton, and inhibit cell migration by up-regulating focal adhesion kinase phosphorylation and Ras homologous G protein activation.There are currently no reviews for this product.